Emeryville, CA (PRWEB) June 07, 2011
BioSoteria, Inc., Drug Safety and Risk Management Specialists, announced today that its Senior Vice President, James Buchanan, PharmD, will present "Signal Detection: MedDRA® and Other Key Issues." Dr. Buchanan will cover methods for identifying safety signals, in both clinical development and post-marketing settings, and how MedDRA® can facilitate the identification of these safety signals. The discussion will include the importance of consistently applying a standardized nomenclature, how groupings of medically relevant terms can facilitate case identification and how such cases are further reviewed to identify safety signals for evaluation. A number of tools available to aid signal detection will be discussed. Finally, a framework will be presented to assist companies to construct a signal detection strategy for their products in clinical development and post-marketing.
His presentation will take place at the 47th Annual DIA Conference in Chicago, Illinois at the MedDRA® user group meeting on Thursday, June 23, 2011 at McCormick Place, Meeting Room Number: West 185 BC from 3:15-4:15PM.
To find out more about the DIA Conference please go to http://www.diahome.org.
Founded in 2007 with a strong vision of a progressive drug safety and pharmacovigilance consulting services and education, BioSoteria serves the outsourcing needs of the pharmaceutical industry. From strategic risk management consulting services and full-service drug safety operational capabilities to world-class award winning pharmacovigilance training and education programs, BioSoteria provides unmatched experience, expertise, and leadership to support your company’s efforts to maximize your product’s benefit-risk profile. For more information and to learn more about BioSoteria’s drug safety services and training programs, go to http://www.biosoteria.com.